MedTrace Logo

Clinical Effectiveness Of High Frequency Chest Wall Oscillation (HFCWO) In A Bronchiectasis Population

NCT04271969 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2023-12-07

No results posted yet for this study

Summary

The primary objective is to compare the patient's baseline QoL prior to HFCWO use against the patient's QoL at various study timepoints over a one-year period of HFCWO use.

Conditions

Interventions

DEVICE

SmartVest Airway Clearance System

Pulmonary airway clearance of retained mucus via high frequency chest wall oscillation (SmartVest)

Sponsors & Collaborators

  • University of Alabama at Birmingham

    collaborator OTHER

  • Electromed, Inc.

    lead INDUSTRY

Principal Investigators

  • George Solomon, MD · University of Alabama at Birmingham

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-18
Primary Completion
2023-12-01
Completion
2023-12-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04271969 on ClinicalTrials.gov